Filed before 2025Filed 3 March 2021
Excision BioTherapeutics Inc raised $10.5M
Excision BioTherapeutics Inc, a biotech company based in San Francisco, CA, raised $10.5M in a new convertible round, according to a filing dated 3 March 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 3 March 2021
- Round
- Convertible round
- Amount sold
- $10.5M
- Offering size
- $10.5M
- Investors so far
- 6
- Based in
- San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 49% of the 2,220 tracked raises with an amount filed in 2021, and than 40% of the 177 in biotech.
Excision BioTherapeutics Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 3 Mar 2021 | New filing | $10.5M | This raise |
| 22 Feb 2021 | New filing | $60.7M | Another raise |
More with GreatPoint Ventures Innovation on the board
- Biobot Analytics, Inc.$13.5M
- Linus Biotechnology Inc.$6.15M
- Invicta Medical, Inc.$25M
- Mythic Inc.$20.5M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.